---
title: "Geographically Weighted Machine Learning Predicts US Cancer Prevalence at Census Tract Level"
id: "medrxiv-16-geographically-weighted-machine-learning-for-spatial-prediction-of-cancer"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-geographically-weighted-machine-learning-for-spatial-prediction-of-cancer"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.18.26360598v1?rss=1"
published_at: "2026-08-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Geographically Weighted Machine Learning Predicts US Cancer Prevalence at Census Tract Level
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-geographically-weighted-machine-learning-for-spatial-prediction-of-cancer
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.18.26360598v1?rss=1)
- **Published At:** 2026-08-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study developed and compared **geographically weighted** and global predictive models to estimate **cancer prevalence** at the census tract level across the United States using 84,415 tracts. - A scoping review produced a list of measurable drivers of cancer; corresponding variables were compiled from the CDC PLACES dataset and other public sources. - Modeling approaches included Ordinary Least Squares (OLS), Geographically Weighted Regression (GWR), Random Forest, XGBoost, Deep Neural Network, and geographically weighted versions of machine learning models. - Model performance was compared with pseudo-R2 (Coefficient of Determination), Root Mean Square Error (RMSE), and Absolute Error metrics. - Geographically weighted models outperformed global approaches; geographically weighted XGBoost showed the strongest and most consistent performance with pseudo-R2 values reported between **0.89 and 0.98**. - Feature importance from the geographically weighted XGBoost model indicated that key drivers of prevalence shifted across locations; influential predictors included older age, racial composition, preventive health behaviors, and metabolic conditions (diabetes, hypertension, high cholesterol). - Results emphasize the value of localized modeling at a small geographic scale to reveal regional cancer risk patterns and guide resource allocation to hotspot areas. - The authors declared no competing interests, confirmed ethical approvals and consent procedures, and stated that data produced are available on reasonable request. - The preprint was posted August 21, 2026, on medRxiv and is available under a CC-BY-NC-ND 4.0 license.
## Clinical Analysis & Structured Key Points
Geographically Weighted Machine Learning for Spatial Prediction of Cancer Prevalence in the United States: A Mixed Method Approach | medRxiv Skip to main content Geographically Weighted Machine Learning for Spatial Prediction of Cancer Prevalence in the United States: A Mixed Method Approach View ORCID Profile Fereshteh Sadeghi Naieni Fard , Joseph R. Oppong , Chetan Tiwari , Kwadwo Boakye , Fariba Fard doi: https://doi.org/10.64898/2026.08.18.26360598 Fereshteh Sadeghi Naieni Fard 1 University of North Texas; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Fereshteh Sadeghi Naieni Fard For correspondence: fereshtehsadeghinaienifard{at}my.unt.edu Joseph R. Oppong 1 University of North Texas; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chetan Tiwari 2 Georgia State University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kwadwo Boakye 3 California State University Find this author on Google Scholar Find this author on PubMed Search for this author on this site Fariba Fard 1 University of North Texas; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Cancer prevalence is distributed unevenly across regions and caused by the interaction of multiple risk factors. Previous studies focused on the use of global modeling techniques to predict cancer at the county level that overlooks important spatial differences. This study aims to develop geographically weighted machine learning models to predict cancer prevalence at the census tract level in the United States and identify local determinants of cancer burden. First, a scoping review was conducted to find a list of measurable drivers of cancer in the United States. Using this list, the data of these variables for 84415 census tracts were obtained from the Center for Disease Control and Prevention PLACES dataset and other publicly accessible resources. Then, several predictive models, including Ordinary Least Squares (OLS) and Geographically Weighted Regression (GWR), as well as Random Forest, XGBoost, and Deep Neural Network and their geographically weighted counterparts, were developed and compared using the Coefficient of Determination, Root Mean Square Error, and Absolute Error. Results presented that geographically weighted models outperformed other methods, and geographically weighted XGBoost achieved the strongest and most consistent overall performance with pseudo-R2 ranging between 0.89 and 0.98. Feature importance analysis of this model illustrated that most important cancer drivers changed location by location. Aged people, racial composition, preventative behaviors, and metabolic conditions such as diabetes, hypertension, and high cholesterol were determined as influential predictors, although their relative importance varied across regions. These findings revealed the value of localized models at a small geographic scale to identify regional cancer risk patterns and help the allocation of proper resources to hotspot areas. Keywords: Cancer prevalence, Census tracts, geographically weighted machine learning models, Deep neural network, XGBoost, Random Forest, Ordinary Least Squares, risk factor, determinant Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted August 21, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Geographically Weighted Machine Learning for Spatial Prediction of Cancer Prevalence in the United States: A Mixed Method Approach Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Geographically Weighted Machine Learning for Spatial Prediction of Cancer Prevalence in the United States: A Mixed Method Approach Fereshteh Sadeghi Naieni Fard , Joseph R. Oppong , Chetan Tiwari , Kwadwo Boakye , Fariba Fard medRxiv 2026.08.18.26360598; doi: https://doi.org/10.64898/2026.08.18.26360598 Share This Article: Copy Citation Tools Geographically Weighted Machine Learning for Spatial Prediction of Cancer Prevalence in the United States: A Mixed Method Approach Fereshteh Sadeghi Naieni Fard , Joseph R. Oppong , Chetan Tiwari , Kwadwo Boakye , Fariba Fard medRxiv 2026.08.18.26360598; doi: https://doi.org/10.64898/2026.08.18.26360598 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (607) Allergy and Immunology (891) Anesthesia (324) Cardiovascular Medicine (4735) Dentistry and Oral Medicine (473) Dermatology (404) Emergency Medicine (637) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1606) Epidemiology (15760) Forensic Medicine (32) Gastroenterology (1193) Genetic and Genomic Medicine (6941) Geriatric Medicine (723) Health Economics (1048) Health Informatics (4936) Health Policy (1417) Health Systems and Quality Improvement (1728) Hematology (574) HIV/AIDS (1322) Infectious Diseases (except HIV/AIDS) (16213) Intensive Care and Critical Care Medicine (1155) Medical Education (657) Medical Ethics (150) Nephrology (714) Neurology (7124) Nursing (359) Nutrition (1066) Obstetrics and Gynecology (1216) Occupational and Environmental Health (992) Oncology (3557) Ophthalmology (1030) Orthopedics (387) Otolaryngology (442) Pain Medicine (463) Palliative Medicine (138) Pathology (702) Pediatrics (1764) Pharmacology and Therapeutics (729) Primary Care Research (754) Psychiatry and Clinical Psychology (5790) Public and Global Health (9635) Radiology and Imaging (2364) Rehabilitation Medicine and Physical Therapy (1418) Respiratory Medicine (1234) Rheumatology (631) Sexual and Reproductive Health (760) Sports Medicine (571) Surgery (756) Toxicology (106) Transplantation (300) Urology (284)
## Related Clinical Research

- [Autologous DC-CIK Cell Therapy Combined with Multidisciplinary Care in Advanced Pancreatic Cancer:](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-multidisciplinary-treatment-incorporating-autologous-dc-cik-cell-therapy.md)
- [Healthy lifestyle and pan-cancer risk: UK Biobank prospective analysis](https://medichelpline.com/clinical-feed/british-journal-of-cancer-2-healthy-lifestyle-and-cancer-risk-a-pan-cancer-analysis-in-the-uk-biobank.md)
- [Combining lymphocyte markers with CA125 and HE4 to improve early endometrial cancer diagnosis in p](https://medichelpline.com/clinical-feed/pubmed-42726666.md) (DOI: 10.1080/01443615.2026.2719764)
- [BioBERT Clinical Text and Sparse Multi-Omics Components for Breast Cancer Survival Prediction: Cro](https://medichelpline.com/clinical-feed/medrxiv-2-biobert-derived-clinical-textrepresentations-and-sparse-principalcomponents-of.md)
- [Pilomatricoma Presenting in an Octogenarian: Rare Late-Life Scalp Tumor Case Report](https://medichelpline.com/clinical-feed/pubmed-42638289.md) (DOI: 10.12659/AJCR.953320)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.